The present invention discloses compounds according to Formula I:Wherein R1, L1, R2, L2, R3, Cy, and the subscript n are as defined herein.The present invention relates to compounds, methods for their production, pharmaceutical compositions comprising the same, and methods of treatment using the same, for the prophylaxis and/or treatment of allergic diseases, inflammatory diseases, metabolic diseases, autoinflammatory diseases, autoimmune diseases, proliferative diseases, transplantation rejection, diseases involving impairment of cartilage turnover, congenital cartilage malformations, and/or diseases associated with hypersecretion of IFNa, IL12 and/or IL23 by administering the compound of the invention.本發明揭示根據式I之化合物：其中R1、L1、R2、L2、R3、Cy及下標n如本文所定義。本發明係關於化合物、用於其等製備之方法、包含其等之醫藥組合物，及使用其等之治療方法，藉由投與本發明之化合物用於預防及/或治療以下疾病：過敏性疾病、發炎性疾病、代謝疾病、自體發炎性疾病、自體免疫疾病、增生性疾病、移植排斥反應、涉及軟骨轉換障礙之疾病、先天性軟骨畸形及/或與IFNα、IL12及/或IL23分泌過多相關聯之疾病。
